期刊文献+

上皮钙黏蛋白及C-erbB-2在非小细胞肺癌中的表达及意义 被引量:3

Expression and meaning of the epithelial cadherin and C-erbB-2 in non-small cell lung cancer
下载PDF
导出
摘要 目的探讨上皮钙黏蛋白(E-cad、β-cat)和C-erbB-2在非小细胞肺癌(NSCLC)中的表达及其相互之间的关系。方法免疫组化SP法检测了41例非小细胞肺癌标本中E-cad、β-cat、C-erbB-2的表达情况。结果 E-cad及β-cat在NSCLC中低表达,并与临床分期、病理分级及淋巴结转移有明显相关性(P<0.05)。C-erbB-2在NSCLC中高表达,且在淋巴结转移组及未转移组间差异有统计学意义(P<0.01)。NSCLC中E-cad与β-cat的表达呈正相关(r=0.36,P<0.01),E-cad与C-erbB-2之间为负相关(r=-0.60,P<0.01),β-cat与C-erbB-2之间的表达亦呈显著性负相关(r=-0.36,P<0.05)。结论 E-cad、β-cat及C-erbB-2在NSCLC的淋巴结转移中起到重要的作用。 Objective To investigate the epithelial cadherin(E-cadherin,E-cad) or β-catenin(β-cat) and C-erbB-2 in non-small cell lung cancer(NSCLC) expression and their mutual relationship.Methods Using immunohistochemical SP method to detect 41 cases of non-small cell lung cancer and from the 15 cases of cancer 5 cm normal lung tissue samples in E-cad,β-cat,C-erbB-2 expression.Results E-cad and β-cat in NSCLC significantly lower expression,both of the clinical stages with NSCLC,pathology classification and lymph node metastasis has a significant relationship(P0.05).2.the C-erbB-2 in NSCLC is a significant high expression,and in the lymph node metastasis group and not transfer between group there was a significant difference(P0.01).3.E-cad and β-cat a positive correlation between the expression(χ2 = 8.67,P0.01,correlation coefficient r=0.36),E-cad and C-erbB-2 for negative correlation between(χ2 = 14.86、 P0.01,correlation coefficient r =-0.60),β-cat and C-erbB-2 of expression between also shows significant negative correlation(χ2 = 5.33,P0.05,correlation coefficient r =-0.36).Conclusion E-cad,β-cat and C-erbB-2 of the lymph node metastasis in NSCLC play an important role in NSCLC.
出处 《中国实验诊断学》 2012年第12期2231-2233,共3页 Chinese Journal of Laboratory Diagnosis
基金 2011年佳木斯大学科研立项课题(S2011026)
关键词 非小细胞肺癌 E-CAD Β-CAT C-ERBB-2 non-small cell lung cancer E-cad β-cat C-erbB-2 immunohistochemistry
  • 相关文献

参考文献7

二级参考文献72

共引文献19

同被引文献31

  • 1Alberg A J, Brock MV, Ford JG, et al. Epidemiology of lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. CHEST Journal, 2013, 143 :el S-e29S.
  • 2Botling J, Edlund K, Lohr M, et al. Biomarker discovery in Non-Small cell lung cancer : Integrating gene expression profiling, meta-analysis, and tissue microarray validation. Clinical Cancer Research ,2013,19 : 194-204.
  • 3Yldrm A, Kosem M, Sayar D, et al. Relationship of PCNA, C-erbB2 and CD44s expression with tumor grade and stage in urothelial carcinomas of the bladder. Internat J Clin Exp Med,2014,7 : 1516-1523.
  • 4Shin SH, Kim SC, Hong SM, et al. Genetic alterations of K-ras, p53, cerbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival. Pancreas,2013,42:216-222.
  • 5Muller PAJ, Vousden KH. p53 mutations in cancer. Nature Cell Biology, 2013,15:2-8.
  • 6Yamamoto M, Hosoda M, Nakano K, et al. p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors. Cancer Science,2014,105:81-88.
  • 7Han F,Liu W, Jiang X, et al, SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in tung cancer. Oneogene ,2014,42 : 116-122.
  • 8Wu HH, Chu YC,Wang L, et al. Cytoplasmic Apel expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer. Annals of Surgical Oncology,2013 ,20 :336-347.
  • 9Baserga R. Growth regulation of the PCNA gene. Journal of Cell Science, 1991,98:433-436.
  • 10Kuang RG,Wu HX,Hao GX,et al. Expression and significance of IGF- 2, PCNA, MMP-7, and α-actin in gastric carcinoma with Lauren classification. Turk J Gastroenterol, 2013,24 : 99-108.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部